Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

Kinatico reports 59% revenue boost, driving HR industry’s replacement with tech

  • In News
  • January 25, 2023
  • Alinda Gupta
Kinatico reports 59% revenue boost, driving HR industry’s replacement with tech

In October 2022, the recruitment screening company CVCheck, or previously CV1 on ASX, got a makeover: a new name, new identity and now, new staff to see it through its new motto, Know Your People.

It is now the regulatory tech company Kinatico (ASX: KYP), comprising solutions including CVCheck (pre-employment background screening), Cited (cloud-based workplace compliance and management), On-Cite (its native mobile app) and Enable (onboarding, verification and mobilisation management).

In Q2 FY23, the Company earned $1 million in revenue from its SaaS business alone, representing a 59% increase on Q2 FY22 and up 32% from Q1 FY23. The total revenue for this quarter amounted to $6.7 million, up only 3% from the prior corresponding period. Overall, the first half revenue comes up to $13.6 million, up 6% on H1 FY22.

Kinatico CEO, Michael Ivanchenko, commented, “It has been exceptionally pleasing to see Kinatico continue to grow revenue despite the problematic macro-economic environment and efficiency gains previously announced have begun to take effect demonstrating the scale of the business.”

The efficiency gains include laying off 19% of its staff. In Kinatico’s world, the idea of robots taking over human jobs rings true as its tech staff was let go due to redundancies and automation. The layoffs give annualised savings of $1.1 million. At the same time, the Company boosted its sales headcount by 25 per cent.

Headquartered in Western Australia, Kinatico is a global regulatory tech aggregator company operating in Australia and New Zealand. Like its previous identity CVCheck, it focuses on employee monitoring and management. And with the new suite of products, it manages the overall workforce and helps employers meet regulatory compliances.

From employee visa status to health, safety and ESG reporting, workplace compliance is a vast field. It is also expensive, given the intricacies involved. Some companies choose to deflect these requirements onto their supply chains; that just makes it more confusing. Kinatico consolidates these issues and comes up with an automated solution. Not only does it consider governance needs (concerning regulatory compliance) but also consumer needs (demanding greater security). 

Ivanchenko expounded, “In the face of this compliance maelstrom, Kinatico’s technology allows businesses to know their people; simply. The Cited and OnCite products solve the problem of real-time compliance monitoring and management. By managing worker credentials and daily compliance workplace requirements in real-time, without creating operational overhead, Kinatico replaces retrospective reporting and shifts the burden from businesses’ compliance teams.”

In the past few months, the Company has grown considerably in emerging sectors, like disability care. Helping such industries be compliant, it has seen an uptick in an H1 uplift month-on-month on an average of 32% growth in supporting organisations with their support workers. Besides that, Kinatico has reached a vast range of employees.

He concluded, “An analysis of Kinatico’s top 50 accounts has found those entities employ more than 1.6 million people globally. The entire Australian workforce is currently 13.8 million.”

The company continues to invest in its on-market buy-back of ordinary shares, with $100k spent in the quarter. With this new identity, Kinatico is set to give the booming HR tech industry stiff competition, one that is likely to land it on top given its broad range of services.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx cv1
  • Cited
  • CVChek
  • kinatico
  • kyp
  • michael ivanchenko
  • OnCite
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.